🇺🇸 FDA

Company profile · Sponsor

Kedrion

Kedrion S.p.A.

ED1B231 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Kedrion (ED1B231) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED1B231
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. KIg10

    Kedrion

    Chronic Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Kedrion?

Kedrion (ED1B231) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Kedrion sponsor?

We track 1 ClinicalTrials.gov-linked program for Kedrion, including KIg10. Open each program for phase, modality, NCT IDs, and indication details.

Where does Kedrion company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.